| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |